SGHT
What one share of Sight Sciences holds
Surgical and Medical Instruments and Apparatus
Our mission is to develop transformative, interventional technologies that allow eyecare providers to procedurally elevate the standards of care – empowering people to keep seeing. We are passionate about improving patients’ lives by helping them to preserve their sight.
Sight Sciences’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.56 |
|---|---|
| Profit | −$0.56 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.44 |
| Cash and investments | $1.46 |
| Debt | $0.75 |
| Book value | $0.97 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | $2.95 | −$3.71 | $0.10 | −$3.54 | — | −$9.34 |
| 2021 | $1.83 | −$2.35 | $0.03 | −$2.00 | — | $4.89 |
| 2022 | $1.49 | −$1.80 | $0.02 | −$1.61 | — | $3.31 |
| 2023 | $1.67 | −$1.14 | $0.02 | −$0.99 | — | $2.45 |
| 2024 | $1.59 | −$1.03 | $0.01 | −$0.45 | — | $1.72 |
| 2025 | $1.48 | −$0.74 | $0.00 | −$0.57 | — | $1.20 |